Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MC4R | P32245 | 4/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390329 | 1.00 | ALOX15 (0.45) | ALOX15CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL17403185 | 0.82 | MMP2 (0.37) | ALOX15CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15808875 | 0.82 | MMP2 (0.40) | ALOX15MMP2ADAM17HPGDMEN1 | |
| SCHEMBL6126088 | 0.78 | ALOX15 (0.41) | ALOX15CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL1454624 | 0.77 | NPC1 (0.46) | LMNARAB9AKMT2A | |
| SCHEMBL15840454 | 0.76 | ALOX15 (0.41) | ALOX15CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL2900705 | 0.75 | USP2 (0.47) | ALOX15CYP3A4HPGDKDM4EMEN1 | |
| SCHEMBL30225671 | 0.75 | USP2 (0.47) | ALOX15CYP3A4HPGDKDM4EMEN1 | |
| SCHEMBL13743627 | 0.75 | USP2 (0.47) | ALOX15CYP3A4HPGDKDM4EMEN1 | |
| SCHEMBL2900708 | 0.75 | USP2 (0.47) | ALOX15CYP3A4HPGDKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981801-B2 | Polypropylene composition | BOREALIS AG (AT) | 2024-05-14 | — | — | US | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| CN-110770264-B | Process for preparing heterophasic propylene copolymers | 博里利斯股份公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-110177798-B | Catalyst and process for preparing same | 博里利斯股份公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| CN-110741039-B | Polypropylene composition | 博里利斯股份公司 | 2022-02-18 | — | — | CN | disclosed |
| US-11078304-B2 | Process for preparing heterophasic propylene copolymers | BOREALIS AG (AT) | 2021-08-03 | — | — | US | disclosed |
| WO-2019007655-A1 | PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | BOREALIS AG (AT) | 2019-01-10 | — | — | WO | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
| EP-3301098-A1 | PROCESS FOR THE PREPARATION OF A LIGAND FOR A CATALYST | Borealis AG (AT) | 2018-04-04 | — | — | EP | disclosed |
| EP-3301098-A1 | PROCESS FOR THE PREPARATION OF A LIGAND FOR A CATALYST | Borealis AG (AT) | 2018-04-04 | — | — | EP | disclosed |
| EP-2935296-B1 | CATALYST | BOREALIS AG (AT) | 2017-11-15 | — | — | EP | disclosed |
| EP-2935296-B1 | CATALYST | BOREALIS AG (AT) | 2017-11-15 | — | — | EP | disclosed |
| US-20150329653-A1 | CATALYST | BOREALIS AG (AT) | 2015-11-19 | — | — | US | disclosed |
| US-20150329653-A1 | CATALYST | BOREALIS AG (AT) | 2015-11-19 | — | — | US | disclosed |
| EP-2935296-A1 | CATALYST | Borealis AG (AT) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014096282-A1 | CATALYST | BOREALIS AG (AT) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | ALOX15 3876/4885CYP3A4 1978/4885CYP1A2 904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.